180 likes | 191 Views
This program aims to address the opioid epidemic in Illinois by providing expanded treatment, recovery support, and prevention programs. Services include outpatient methadone treatment, recovery home services, Vivitrol assisted services for county jail inmates, hospital warm hand-off services, community outreach and referral services, Rush Hospital multi-disciplinary programs, opioid crisis helpline, improved EHR opioid-prescriber reporting, and expanded naloxone distribution services.
E N D
Illinois Department of Human Services Richard E. Sherman, Ph.D., Project Director, Opioid State Targeted Response (STR) Grant
Illinois Opioid-STR Grant Award – TI-080231 • The federal 21st Century Cures Act includes allocation of about $1 billion to states over two years in support of programs to address the nationwide opioid epidemic. • Illinois received a formula-based Opioid-STR grant level of $16,328,583 for each of two years. • IDHS/DASA prepared an application that was submitted on 02/17/17 and a notice of grant award was received for Year 1 (05/01/17-04/30/18).
Illinois Opioid-STR Grant Award – TI-080231 • The Illinois application proposed a variety of treatment, recovery support, prevention/intervention and public awareness/information service programs. • SAMHSA specified data collection requirements have to be met for persons to be counted towards these targets. These are primarily demographic items. • IDHS chose to expand upon these minimally-required data collection expectations in order to provide additional outcome-related service information.
Highlights of Illinois Opioid-STR Treatment, Recovery Support and Prevention Programs • Expanded Outpatient Methadone Treatment (OMT). Twelve (12) community-based licensed organizations have been contracted to provide these services through the Opioid-STR grant. As of February 8, 2018, 1,513 clients have been admitted to these services. • Expanded Recovery Home Services for Persons with OUD. IDHS/DASA contracted with three organizations to provide expanded recovery home services. Being active in some form of Medication Assisted Treatment (MAT) is a requirement. 22 clients have thus far been admitted to these services.
Highlights of Illinois Opioid-STR Treatment, Recovery Support and Prevention Programs • Vivitrol Assisted Services for County Jail Inmates. Services have been implemented in eight county jails and 184 persons have been served, with 93.5% (700) of the released offenders being admitted to the community-based treatment providers to which they were referred. • Hospital Warm Hand-off Services for Persons with OUD. Services have been initiated at six hospitals and 844 patients have been served to-date, with 82.9% being admitted by the treatment providers to which they were referred.
Highlights of Illinois Opioid-STR Treatment, Recovery Support and Prevention Programs • Community Outreach/Linkage/Referral Services. Through December 2017, 2,108 persons were provided outreach services, 766 screened positive for opioid use and expressed an interest in treatment, 459 completed a linkage meeting, and 363 showed for a treatment intake. • Rush Hospital Multi-Disciplinary Programs. Opioid-STR funds also support multiple programs with Rush University Hospital. Through January 31, 2018, Rush provided SBIRT services to 1,149 inpatients, of whom 286 screened positive for any SUD, with 93 of these inpatients screening positive for OUD.
Highlights of Illinois Opioid-STR Treatment, Recovery Support and Prevention Programs • Opioid Crisis Helpline. Illinois Opioid-STR funds support a statewide 24/7/365 helpline for persons with OUD-related issues. The initial version of this helpline was launched on December 5, 2017 by Governor Rauner. The helpline received 1,312 calls as of February 9, 2018. • Improved EHR Opioid-Prescriber Reporting. Opioid-STR funds to the IDHS OCAPS Bureau of Pharmacy and Clinical Support Services support improved opioid prescriber reporting functionality in commonly used EHR systems. There are currently 31 PMP/EHR connectivity implementations in the planning, development, or testing phases, with 27 current connections that made 2,222,730 requests in December 2017.
Highlights of Illinois Opioid-STR Treatment, Recovery Support and Prevention Programs • Expanded Naloxone Distribution Services. The major portion of Illinois Opioid-STR prevention funding support an expansion of naloxone distribution services to the 96 of Illinois’ 102 counties that are not represented in the 2016 SAMHSA/CSAP Prescription Drug/Opioid (PDO) Overdose grant to IDHS. To-date, there have been 1,685 individuals trained through the STR-funded services, 2,294 Naloxone kits have been distributed, and 152 opioid overdose reversals have been reported.
Summary of STR Expanded OMT Client Characteristics: 02/01/2018 – N = 1,471 • Male – 59.6%; Female – 40.0%; Transgender – 0.2% • Average Age: 49.5 years • Living Arrangements – Own House/Apt.: 41.3% • African American – 73.6%; White – 17.7% • Hispanic/Latino – 9.2% • Employed: Full-time – 5.4%; Part-time – 5.0% • Have Children – 74.8% (average – 3.2) • Avg. Money Spent on Drugs/Past 30 Days - $1,521 • On Probation/Parole – 12.5% • Avg. Days of Heroin Use/Past 30 Days – 27.3 • Injection Drug Use/Past 30 Days – 16.9%
Illinois Opioid-STR Expanded OMT Clients Interim Summary of Six-Month Follow-up Data • A version of the standard SAMHSA Center for Substance Abuse Treatment (CSAT) Data Collection tool is being administered to STR OMT clients at six-month post-admission follow-up • The expanded OMT clients first came due for follow-up in November 2017, and as of January 31, 2018 six-month follow-up interviews had been completed with 190 clients. • Several statistically significant changes from baseline to follow-up were observed among the contacted clients.
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesCurrent Employment Status – Full-time or Part-timeComparison Significant: Chi-Square (χ) = 18.28, p=.006, d.f. = 6
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesAverage Money Spent on Illegal Drugs/Past 30 DaysComparison Significant: Wilcoxon Z = -11.22, p <.001
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesFeelings of Stress Due to Substance Use/Not at All or N.A.Comparison Significant: Chi-Square (χ) = 116.93, p<.001, d.f. = 3
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesReduction in Important Activities Due to Substance Use/Not at All or N.A.Comparison Significant: Chi-Square (χ) = 135.38, p<.001, d.f. = 3
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesEmotional Problems Due to Substance Use/Not at All or N.A.Comparison Significant: Chi-Square (χ) = 68.17, p<.001, d.f. = 3
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesAverage Days of Heroin Use/Past 30 DaysComparison Significant: Wilcoxon Z = -11.27, p <.001
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesAbstinent Rate – Heroin Use/Past 30 Days Comparison Significant: Chi-Square (χ) = 101.32, p<.001, d.f. = 1
Comparison of STR OMT Client Baseline to Six-Month Follow-up ChangesInjection Drug Use/Past 30 Days Comparison Significant: Chi-Square (χ) = 15.98, p<.001, d.f. = 1